8-K Reports
AIM ImmunoTech Inc.
CIK

946644

Accepted

Jul 16, 2026, 08:05 PM

Accession

0001493152-26-033514

5.07 Submission of Matters to a Vote of Security Holders
Items (1)

Item 5.07 Submission of Matters to a Vote of Security Holders A Special Meeting of Stockholders (the “ Special Meeting”) of AIM ImmunoTech Inc. (the “ Company”) was held on July 15, 2026. As of the record date for the Special Meeting, there were 27,724,245 outstanding shares of the Company’s common stock outstanding and entitled to vote at the Special Meeting. Of the record date outstanding shares, 10,671,690 shares, or approximately 38.5%, were represented at the Special Meeting either in person or by proxy, meaning the requisite quorum for the meeting of 33 and 1/3% was present. Set forth below are the matters voted upon at the Special Meeting, which are more fully described in the Company’s definitive proxy statement filed with the U. S. Securities and Exchange Commission on June 25, 2026, and the final voting results received from the inspector of elections for the Special Meeting (the “ Inspector of Elections”). Proposal 1: To approve, for purposes of complying with NYSE American Company Guide Sections 713(a) and 713(b), the issuance of more than 19.99% of the Company’s issued and outstanding shares of common stock, upon the exercise of the Class H common stock purchase warrants, pursuant to the warrant exercise inducement offer letter agreement dated May 7, 2026: For: Against: Abstain: Broker Non-Votes: ────────────────────────────────────────────────────────── 2,677,035 1,312,258 149,248 6,533,150 Based on the final voting results reported by the Inspector of Election, Proposal 1 was approved. Proposal 2: To approve, for purposes of complying with NYSE American Company Guide Sections 713(a) and 713(b), the issuance of more than 19.99% of the Company’s issued and outstanding shares of common stock, upon the exercise of the Class I common stock purchase warrants, pursuant to the securities purchase agreement dated May 20, 2026: For: Against: Abstain: Broker Non-Votes: ────────────────────────────────────────────────────────── 2,676,038 1,317,709 144,794 6,533,150 Based on the final voting results reported by the Inspector of Election, Proposal 2 was approved. Proposal 3: To approve, for purposes of complying with NYSE American Company Guide Sections 713(a) and 713(b), the issuance of more than 19.99% of the Company’s issued and outstanding shares of common stock, upon the exercise of the Class J common stock purchase warrants, pursuant to the securities purchase agreement dated June 9, 2026: For: Against: Abstain: Broker Non-Votes: ────────────────────────────────────────────────────────── 2,684,308 1,301,624 152,610 6,533,150 Based on the final voting results reported by the Inspector of Election, Proposal 3 was approved. Proposal 4: To approve, for purposes of complying with NYSE American Company Guide Sections 713(a) and 713(b), the issuance of more than 19.99% of the Company’s issued and outstanding shares of common stock, upon the conversion or other satisfaction of that certain promissory note dated February 16, 2024: For: Against: Abstain: Broker Non-Votes: ────────────────────────────────────────────────────────── 2,676,665 1,309,155 152,722 6,533,150 Based on the final voting results reported by the Inspector of Election, Proposal 4 was approved. Proposal 5: To approve, for purposes of complying with NYSE American Company Guide Sections 713(a) and 713(b), the issuance of more than 19.99% of the Company’s issued and outstanding shares of common stock, upon the conversion or other satisfaction of that certain promissory note dated November 18, 2025: For: Against: Abstain: Broker Non-Votes: ────────────────────────────────────────────────────────── 2,673,399 1,312,327 152,816 6,533,150 Based on the final voting results reported by the Inspector of Election, Proposal 5 was approved. Proposal 6: To approve a series of alternate amendments to our Certificate of Incorporation to effect, at the option of our Board of Directors, a reverse stock split of our outstanding common stock at a ratio in the range of up to 1-for-25, with such ratio to be determined by our Board of Directors in its sole discretion: For: Against: Abstain: Broker Non-Votes: ────────────────────────────────────────────────────────── 7,344,727 3,315,347 11,616 – Based on the final voting results reported by the Inspector of Election, Proposal 6 was approved. Proposal 7: To approve an adjournment of the Special Meeting to a later date or time, if necessary, to permit further solicitation of proxies if there are insufficient votes at the time of the Special Meeting to approve any of the other proposals presented for a vote at the Special Meeting: For: Against: Abstain: Broker Non-Votes: ────────────────────────────────────────────────────────── 7,380,255 2,938,798 352,637 – Based on the final voting results reported by the Inspector of Election, Proposal 7 was approved. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AIM Date: By: /s/ Thomas